BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7113601)

  • 1. Spontaneous development of hyperprolactinaemia.
    Rjosk HK; Fahlbusch R; von Werder K
    Acta Endocrinol (Copenh); 1982 Jul; 100(3):333-6. PubMed ID: 7113601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of pregnancies on prolactinomas.
    Rjosk HK; Fahlbusch R; von Werder K
    Acta Endocrinol (Copenh); 1982 Jul; 100(3):337-46. PubMed ID: 7113602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The preoperative and postoperative investigation of TSH and prolactin release in the management of patients with hyperprolactinaemia due to prolactinomas and nonfunctional pituitary tumours: relationship to adenoma size at surgery.
    Scanlon MF; Peters JR; Salvador J; Richards SH; John R; Howell S; Williams ED; Thomas JP; Hall R
    Clin Endocrinol (Oxf); 1986 Apr; 24(4):435-46. PubMed ID: 3091297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of pituitary adenoma in women with hyperprolactinaemia: clinical, endocrine, and radiological characteristics.
    Pontiroli AE; Falsetti L
    Br Med J (Clin Res Ed); 1984 Feb; 288(6416):515-8. PubMed ID: 6421360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The occurrence of macroscopical pituitary calcifications in prolactinomas.
    Rasmussen C; Larsson SG; Bergh T
    Neuroradiology; 1990; 31(6):507-11. PubMed ID: 2352634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolactin secretion in patients with chromophobe adenomas of the pituitary: incidence and presentation of hyperprolactinaemia: results of surgical treatment.
    Franks S; Nabarro JD
    Ann Clin Res; 1978; 10(3):157-63. PubMed ID: 718118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperprolactinaemia in males with and without pituitary macroadenomas.
    Spark RF; Wills CA; O'Reilly G; Ransil BJ; Bergland R
    Lancet; 1982 Jul; 2(8290):129-32. PubMed ID: 6123841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and drug therapy of prolactinoma.
    Ciccarelli E; Camanni F
    Drugs; 1996 Jun; 51(6):954-65. PubMed ID: 8736617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asymptomatic hyperprolactinaemia and prolactinoma in the general population--mass screening by paired assays of serum prolactin.
    Miyai K; Ichihara K; Kondo K; Mori S
    Clin Endocrinol (Oxf); 1986 Nov; 25(5):549-54. PubMed ID: 3621622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follow-up of patients with prolactinomas after discontinuation of long-term therapy with bromocriptine.
    Zárate A; Canales ES; Cano C; Pilonieta CJ
    Acta Endocrinol (Copenh); 1983 Oct; 104(2):139-42. PubMed ID: 6356741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do the limits of serum prolactin in disconnection hyperprolactinaemia need re-definition? A study of 226 patients with histologically verified non-functioning pituitary macroadenoma.
    Karavitaki N; Thanabalasingham G; Shore HC; Trifanescu R; Ansorge O; Meston N; Turner HE; Wass JA
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):524-9. PubMed ID: 16984247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Computerized tomography of the pituitary gland in the diagnosis of prolactinoma: a concordance study].
    Soriguer Escofet FJ; Rodríguez Navarro MP; Rodríguez San Pedro F; Sanz JM; Esteva de Antonio I; García Arnés JA; Escolar Castellón JL; Mazuecos F
    Med Clin (Barc); 1991 Sep; 97(9):331-4. PubMed ID: 1961060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum prolactin bioactivity and immunoactivity in hyperprolactinaemic states.
    Smith CR; Butler J; Hashim I; Norman MR
    Ann Clin Biochem; 1990 Jan; 27 ( Pt 1)():3-8. PubMed ID: 2310154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and presentation of hyperprolactinaemia in patients with "functionless" pituitary tumours.
    Franks S; Nabarro JD
    Lancet; 1977 Apr; 1(8015):778-80. PubMed ID: 66572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The value of functional tests in diagnosis of prolactinoma].
    Klockenbusch W; Distler W; von Ditfurth M; Graf M; Jahn K
    Geburtshilfe Frauenheilkd; 1990 May; 50(5):383-7. PubMed ID: 2115483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galactorrhoea and hypogonadism associated with a radiologically-inapparent prolactin-secreting pituitary tumour.
    McKenna TJ; Glick AD; Cobb CA; Jacobs LS
    Acta Endocrinol (Copenh); 1978 Feb; 87(2):225-33. PubMed ID: 415470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tests of prolactin secretion in diagnosis of prolactinomas.
    Cowden EA; Ratcliffe JG; Thomson JA; Macpherson P; Doyle D; Teasdale GM
    Lancet; 1979 Jun; 1(8127):1155-8. PubMed ID: 86882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CT abnormalities of the pituitary in hyperprolactinaemic women with normal or equivocal sellae radiologically.
    Jung RT; White MC; Bowley NB; Bydder G; Mashiter K; Joplin GF
    Br Med J (Clin Res Ed); 1982 Oct; 285(6348):1078-81. PubMed ID: 6812753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolactin secretion by mixed ACTH-prolactin pituitary adenoma cells in culture.
    Yamaji T; Ishibashi M; Teramoto A; Fukushima T
    Acta Endocrinol (Copenh); 1985 Apr; 108(4):456-63. PubMed ID: 2859725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of an intravenous TRH test for the diagnosis of tumoural prolactinaemia.
    Assies J; Schellekens AP; Touber JL
    Acta Endocrinol (Copenh); 1980 Aug; 94(4):439-49. PubMed ID: 6776747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.